The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Rotavirus Vaccine Market Research Report 2024
Synopsis
An oral vaccine against rotavirus infection is given to babies as part of their routine childhood vaccinations.
The global Oral Rotavirus Vaccine market was valued at US$ 7215 million in 2023 and is anticipated to reach US$ 14890 million by 2030, witnessing a CAGR of 12.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rotavirus Vaccine.
Report Scope
The Oral Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Rotavirus Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Segment by Application
Hospital
Vaccination Station
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Rotavirus Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
An oral vaccine against rotavirus infection is given to babies as part of their routine childhood vaccinations.
The global Oral Rotavirus Vaccine market was valued at US$ 7215 million in 2023 and is anticipated to reach US$ 14890 million by 2030, witnessing a CAGR of 12.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rotavirus Vaccine.
Report Scope
The Oral Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Rotavirus Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Segment by Application
Hospital
Vaccination Station
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Rotavirus Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.3 Market by Application
1.3.1 Global Oral Rotavirus Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Vaccination Station
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Rotavirus Vaccine Market Perspective (2019-2030)
2.2 Oral Rotavirus Vaccine Growth Trends by Region
2.2.1 Global Oral Rotavirus Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Rotavirus Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Oral Rotavirus Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Oral Rotavirus Vaccine Market Dynamics
2.3.1 Oral Rotavirus Vaccine Industry Trends
2.3.2 Oral Rotavirus Vaccine Market Drivers
2.3.3 Oral Rotavirus Vaccine Market Challenges
2.3.4 Oral Rotavirus Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Rotavirus Vaccine Players by Revenue
3.1.1 Global Top Oral Rotavirus Vaccine Players by Revenue (2019-2024)
3.1.2 Global Oral Rotavirus Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Rotavirus Vaccine Revenue
3.4 Global Oral Rotavirus Vaccine Market Concentration Ratio
3.4.1 Global Oral Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Rotavirus Vaccine Revenue in 2023
3.5 Oral Rotavirus Vaccine Key Players Head office and Area Served
3.6 Key Players Oral Rotavirus Vaccine Product Solution and Service
3.7 Date of Enter into Oral Rotavirus Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Rotavirus Vaccine Breakdown Data by Type
4.1 Global Oral Rotavirus Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Oral Rotavirus Vaccine Forecasted Market Size by Type (2025-2030)
5 Oral Rotavirus Vaccine Breakdown Data by Application
5.1 Global Oral Rotavirus Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Oral Rotavirus Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Rotavirus Vaccine Market Size (2019-2030)
6.2 North America Oral Rotavirus Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oral Rotavirus Vaccine Market Size by Country (2019-2024)
6.4 North America Oral Rotavirus Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Rotavirus Vaccine Market Size (2019-2030)
7.2 Europe Oral Rotavirus Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oral Rotavirus Vaccine Market Size by Country (2019-2024)
7.4 Europe Oral Rotavirus Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Rotavirus Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Oral Rotavirus Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oral Rotavirus Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Oral Rotavirus Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Rotavirus Vaccine Market Size (2019-2030)
9.2 Latin America Oral Rotavirus Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oral Rotavirus Vaccine Market Size by Country (2019-2024)
9.4 Latin America Oral Rotavirus Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Rotavirus Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Oral Rotavirus Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oral Rotavirus Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Oral Rotavirus Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Oral Rotavirus Vaccine Introduction
11.1.4 GSK Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Company Detail
11.2.2 Sanofi-Pasteur Business Overview
11.2.3 Sanofi-Pasteur Oral Rotavirus Vaccine Introduction
11.2.4 Sanofi-Pasteur Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.2.5 Sanofi-Pasteur Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Oral Rotavirus Vaccine Introduction
11.3.4 Merck Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Biological E. Limited
11.4.1 Biological E. Limited Company Detail
11.4.2 Biological E. Limited Business Overview
11.4.3 Biological E. Limited Oral Rotavirus Vaccine Introduction
11.4.4 Biological E. Limited Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.4.5 Biological E. Limited Recent Development
11.5 China National Biotec Group
11.5.1 China National Biotec Group Company Detail
11.5.2 China National Biotec Group Business Overview
11.5.3 China National Biotec Group Oral Rotavirus Vaccine Introduction
11.5.4 China National Biotec Group Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.5.5 China National Biotec Group Recent Development
11.6 Sinovac Biotech
11.6.1 Sinovac Biotech Company Detail
11.6.2 Sinovac Biotech Business Overview
11.6.3 Sinovac Biotech Oral Rotavirus Vaccine Introduction
11.6.4 Sinovac Biotech Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.6.5 Sinovac Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
